What is Study Design?

Study design is the overall plan or framework of a clinical trial that defines how the study is structured and conducted to answer specific research questions. It describes elements such as the type of study (e.g., randomized, blinded, controlled), treatment groups, duration, sample size, and methods for data collection and analysis.

A well-defined study design ensures the trial is scientifically valid, unbiased, and ethically sound, helping generate reliable results while protecting participant safety.

The protocol serves as a reference document for investigators, sponsors, and regulators, guiding all trial activities and helping protect participant safety while ensuring reliable and compliant study results.

In clinical trials, study design is used during the planning and execution phases to define how the study will be conducted and how outcomes will be measured. It determines the overall structure of the trial, including treatment groups, randomization methods, endpoints, and analysis approach.

Within this framework, treatment definition in statistics specifies how each treatment arm is categorized and compared, ensuring clarity in data analysis. Measures such as the RR formula (Relative Risk) are applied during analysis to evaluate and compare outcomes between treatment groups. Together, study design, treatment definitions, and statistical measures guide consistent trial conduct and support scientifically valid conclusions.

Clinion enables study design by configuring clinical trial systems to reflect the planned trial structure, treatment arms, and analysis requirements. The study design details are translated into system workflows, visit schedules, and treatment group setups, ensuring consistent execution across sites.

By defining treatment definitions in statistics within the system and facilitating statistical outputs such as the RR formula (Relative Risk) during analysis, Clinion helps ensure that data is captured, grouped, and analyzed in line with the approved study design, supporting accurate and reliable trial results.

During trial conduct, study design is reflected in the system as clearly defined treatment arms, visit schedules, and workflows based on the approved trial plan. Each subject is assigned to a treatment group, and the system guides sites through protocol-defined visits and assessments.

During analysis, the treatment definition in statistics is already structured in the data, allowing outcomes to be compared across groups. Measures such as the RR formula (Relative Risk) can then be applied easily, providing a clear view of treatment effects aligned with the study design.

Study Design

Protocol Amendment

GCP

Clinion eProtocol | AI-Powered Clinical Trial Protocol Generation
Clinical Trial Protocol Optimization with Generative AI
Faster Study Start with eProtocol Automation for Trials
What is a Clinical Trial Protocol? Roles, Structure & Importance

Study Setup & Design